share_log

Insiders At Merit Medical Systems Sold US$4.4m In Stock, Alluding To Potential Weakness

Insiders At Merit Medical Systems Sold US$4.4m In Stock, Alluding To Potential Weakness

Merit Medical Systems的内部人士出售了440万美元的股票,暗示潜在的疲软
Simply Wall St ·  2023/10/15 08:54

The fact that multiple Merit Medical Systems, Inc. (NASDAQ:MMSI) insiders offloaded a considerable amount of shares over the past year could have raised some eyebrows amongst investors. Knowing whether insiders are buying is usually more helpful when evaluating insider transactions, as insider selling can have various explanations. However, shareholders should take a deeper look if several insiders are selling stock over a specific time period.

在过去的一年中,多位Merit Medical Systems, Inc.(纳斯达克股票代码:MMSI)内部人士抛售了大量股票,这一事实可能会引起投资者的关注。在评估内幕交易时,了解内部人士是否在买入通常更有帮助,因为内幕卖出可以有多种解释。但是,股东应更深入地研究是否有几位内部人士在特定时间段内出售股票。

Although we don't think shareholders should simply follow insider transactions, logic dictates you should pay some attention to whether insiders are buying or selling shares.

尽管我们认为股东不应该简单地关注内幕交易,但逻辑要求你应该注意内部人士是在买入还是卖出股票。

View our latest analysis for Merit Medical Systems

查看我们对 Merit 医疗系统的最新分析

Merit Medical Systems Insider Transactions Over The Last Year

Merit Medical Systems 去年内幕交易

Over the last year, we can see that the biggest insider sale was by the Founder, Fred Lampropoulos, for US$1.7m worth of shares, at about US$68.43 per share. That means that an insider was selling shares at around the current price of US$64.63. We generally don't like to see insider selling, but the lower the sale price, the more it concerns us. Given that the sale took place at around current prices, it makes us a little cautious but is hardly a major concern.

在过去的一年中,我们可以看到,最大的内幕出售是创始人弗雷德·兰普罗普洛斯,以每股约68.43美元的价格出售了价值170万美元的股票。这意味着一位内部人士正在以目前的64.63美元左右的价格出售股票。我们通常不喜欢看到内幕销售,但是销售价格越低,我们就越担心。鉴于此次出售是以当前价格进行的,这使我们有点谨慎,但并不是一个主要问题。

Insiders in Merit Medical Systems didn't buy any shares in the last year. You can see a visual depiction of insider transactions (by companies and individuals) over the last 12 months, below. If you want to know exactly who sold, for how much, and when, simply click on the graph below!

去年,Merit Medical Systems的内部人士没有购买任何股票。你可以在下面看到过去 12 个月的内幕交易(公司和个人)的直观描述。如果你想确切地知道谁卖了、卖了多少以及何时出售,只需点击下图!

insider-trading-volume
NasdaqGS:MMSI Insider Trading Volume October 15th 2023
纳斯达克GS: MMSI 内幕交易量 2023 年 10 月 15 日

If you are like me, then you will not want to miss this free list of growing companies that insiders are buying.

如果你像我一样,那么你不会想错过这份业内人士正在收购的成长型公司的免费名单。

Insider Ownership Of Merit Medical Systems

Merit医疗系统的内部所有权

Another way to test the alignment between the leaders of a company and other shareholders is to look at how many shares they own. We usually like to see fairly high levels of insider ownership. Merit Medical Systems insiders own about US$85m worth of shares. That equates to 2.3% of the company. While this is a strong but not outstanding level of insider ownership, it's enough to indicate some alignment between management and smaller shareholders.

检验公司领导者与其他股东之间一致性的另一种方法是查看他们拥有多少股票。我们通常希望看到相当高的内部所有权水平。Merit Medical Systems内部人士拥有价值约8500万美元的股票。这相当于该公司的2.3%。尽管这是内部人所有权强劲但并不突出的水平,但这足以表明管理层与小股东之间有一定的一致性。

What Might The Insider Transactions At Merit Medical Systems Tell Us?

Merit Medical Systems 的内幕交易会告诉我们什么?

It doesn't really mean much that no insider has traded Merit Medical Systems shares in the last quarter. Our analysis of Merit Medical Systems insider transactions leaves us cautious. The modest level of insider ownership is, at least, some comfort. Of course, the future is what matters most. So if you are interested in Merit Medical Systems, you should check out this free report on analyst forecasts for the company.

上个季度没有内部人士交易过Merit Medical Systems的股票,这并没有多大意义。我们对Merit Medical Systems内幕交易的分析使我们保持谨慎。内部所有权的适度水平至少让人感到欣慰。当然,未来才是最重要的。因此,如果你对Merit Medical Systems感兴趣,你应该查看这份关于该公司分析师预测的免费报告。

But note: Merit Medical Systems may not be the best stock to buy. So take a peek at this free list of interesting companies with high ROE and low debt.

但请注意:Merit Medical Systems可能不是最好的买入股票。因此,来看看这份投资回报率高、债务低的有趣公司的免费清单。

For the purposes of this article, insiders are those individuals who report their transactions to the relevant regulatory body. We currently account for open market transactions and private dispositions of direct interests only, but not derivative transactions or indirect interests.

就本文而言,内部人士是那些向相关监管机构报告交易的个人。我们目前仅对公开市场交易和直接权益的私人处置进行核算,但不包括衍生品交易或间接权益。

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

对这篇文章有反馈吗?对内容感到担忧?直接联系我们。 或者,给编辑团队 (at) simplywallst.com 发送电子邮件。
Simply Wall St 的这篇文章本质上是笼统的。我们仅使用公正的方法提供基于历史数据和分析师预测的评论,我们的文章并非旨在提供财务建议。它不构成买入或卖出任何股票的建议,也没有考虑到您的目标或财务状况。我们的目标是为您提供由基本数据驱动的长期重点分析。请注意,我们的分析可能不会考虑最新的价格敏感型公司公告或定性材料。华尔街只是没有持有上述任何股票的头寸。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发